The combination of duloxetine and bupropion for treatment-resistant major depressive disorder

Depression and Anxiety

Volumn 23, Issue 3, 2006, Pages 178-181

  Papakostas, George I ^a   Worthington III, John J ^a   Iosifescu, Dan V ^a   Kinrys, Gustavo ^b   Burns, Alana M ^a   Fisher, Lauren B ^a   Homberger, Caitlin H ^a   Mischoulon, David ^a   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Anxiety Disorders Research Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DULOXETINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGITATION; ARTICLE; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DEPRESSION; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERHIDROSIS; HYPERTENSION; INSOMNIA; MAJOR DEPRESSION; MALE; MENTAL DISEASE; NAUSEA; PRIORITY JOURNAL; PRURITUS; PSYCHOPHARMACOTHERAPY; SEXUAL DYSFUNCTION; SIDE EFFECT; TREATMENT OUTCOME; WEIGHT GAIN; XEROSTOMIA;

ADULT; ANTIDEPRESSIVE AGENTS; BUPROPION; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THIOPHENES; TREATMENT OUTCOME;

EID: 33646542736     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20181     Document Type: Article

References (7)

1. Bodkin JA, Lasser RA, Wines JD Jr, Gardner DM, Baldessarini RJ. 1997. Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J Clin Psychiatry 58:137-145.
2. DeBattista C, Solvason HB, Poirier J, Kendrick E, Schatzberg AF. 2003. A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants. J Clin Psychopharmacol 23:27-30.
3. Goldstein DJ, Lu Y, Detke MJ, Wiltse C, Mallinckrodt C, Demitrack MA. 2004. Duloxetine in the treatment of depression: A double-blind placebo-controlled comparison with paroxetine. J Clin Psychopharmacol 24:389-399.
4. Guy W, editor. 1976. ECDEU assessment manual for psychopharmacology, revised [DHEW Pub. No. (ADM) 76-338]. Rockville, MD: National Institute of Mental Health.
5. Kennedy SH, McCann SM, Masellis M, McIntyre RS, Raskin J, McKay G, Baker GB. 2002. Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: A preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. J Clin Psychiatry 63:181-186.
6. Mischoulon D, Nierenberg AA, Kizilbash L, Rosenbaum JF, Fava M. 2000. Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians. Can J Psychiatry 45:476-481.
7. Thase ME, Entsuah AR, Rudolph RL. 2001. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 178:234-241.